Atlas Trials

Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

Clinical trial NCT00251082 · COMPLETED

Trial details

NCT number
NCT00251082
Sponsor
Solvay Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Postmenopause
Start date
2005-12-01
Primary completion
2007-10-01
Enrollment
391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.